BANGKOK, THAILAND. – Cannabis, a plant long surrounded by controversy, is now at the forefront of medical innovation. With its compounds, Cannabidiol (CBD) and Tetrahydrocannabinol (THC), it’s offering new hope in the field of medicine.
CBD, known for its stress-relieving properties, is not classified as a narcotic and does not produce psychoactive effects. It’s increasingly used to alleviate inflammation, protect nerve cells, and improve the quality of life for end-stage patients. On the other hand, THC, while still a controlled substance, is recognized for its ability to induce relaxation and reduce symptoms like pain and nausea, especially in cancer patients undergoing chemotherapy.
However, the use of these compounds is not without its challenges. As PPTV Online reports, “CBD and THC are not first-line treatments but are considered based on the physician’s discretion.” The use of CBD and THC must be carefully monitored, particularly in sensitive groups such as children, pregnant women, and nursing mothers, due to potential direct effects on fetuses and infants.
The Thai Ministry of Public Health has taken steps to educate both medical professionals and the public about the cautious use of these compounds. A guidebook has been created to inform tourists and locals alike about the benefits and risks associated with CBD and THC.
In conclusion, while cannabis-derived compounds offer promising medical benefits, their application requires careful consideration and professional guidance to ensure patient safety and efficacy.
Source: PPTV Online
